QA: ALPINE IMMUNE SCIENCES INC. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2018_ALPINE_IMMUNE_SCIENCES_INC.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'IMMUNE DESIGN CORP.', 'shared_tokens': {'immune'}}]}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.0015512986249853096, 'aggregate_val': 85222000, 'exp_sum': 85090000, 'exp_to_value': {'AssetsCurrent': 82548000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 1089000, 'remainder_Assets': 1453000}}

Graph

Absolute values for 0001626199, ALPINE IMMUNE SCIENCES INC.

  xvar xval
0 AssetsCurrent 82,548,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,089,000
3 remainder_Assets 1,585,000
4 LiabilitiesCurrent 1,895,000
5 LiabilitiesNoncurrent 4,039,000
6 remainder_Liabilities 371,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,079,000
9 ResearchAndDevelopmentExpense 10,626,000
10 remainder_Expenses -48,000
11 remainder_Revenues 542,000
12 remainder_NetIncome 8,332,000
13 remainder_ComprehensiveNetIncome -59,000
  yvar yval
0 Assets 85,222,000
1 Liabilities 6,305,000
2 Expenses 16,657,000
3 Revenues 542,000
4 StockholdersEquity 78,917,000
5 NetIncome -7,783,000
6 ComprehensiveNetIncome -7,812,500
7 BaseVar 58,558,500
8 EconomicCapitalRatio 2.80

Edgar->Model Mapping

Feature Distribution

Change over Time